1 week Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell?Investor's Business Daily
Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell?
The post Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? appeared first on Invest…